Lexicon Pharmaceuticals
LXRX
$1.58
Share price
2.60%
Change (1 day)
-33.89%
Change (1 year)
Categories
Earnings for Lexicon Pharmaceuticals (LXRX)
Earnings in 2023 (TTM): -$0.18 B
According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.18 B. In 2022 the company made an earning of -$0.11 B a decrease over its 2021 earnings that were of -$87.76 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Lexicon Pharmaceuticals from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.18 B | 73.74% |
| 2022 | -$0.11 B | 16.16% |
| 2021 | -$87.76 M | 49.82% |
| 2020 | -$58.58 M | -147.19% |
| 2019 | $0.12 B | -203.42% |
| 2018 | -$0.13 B | -15.31% |
| 2017 | -$0.15 B | 0.2% |
| 2016 | -$0.15 B | 2920.7% |
| 2015 | -$4.69 M | -95.33% |
| 2014 | -$0.11 B | -3.61% |
| 2013 | -$0.11 B | -5.52% |
| 2012 | -$0.12 B | -4.17% |
| 2011 | -$0.12 B | 15.5% |
| 2010 | -$99.58 M | 8.36% |
| 2009 | -$91.9 M | -4.81% |
| 2008 | -$96.54 M | 28.79% |
| 2007 | -$74.96 M | 35.71% |
| 2006 | -$55.24 M | 52.91% |
| 2005 | -$36.12 M | -23.89% |
| 2004 | -$47.46 M | -24.19% |
| 2003 | -$62.6 M | -0.48% |
| 2002 | -$62.9 M | 44.12% |
| 2001 | -$43.64 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $6.29 B | -3,655.80% | 🇺🇸 USA |
 Illumina ILMN | -$1.04 B | 487.18% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $4.19 B | -2,470.89% | 🇺🇸 USA |
 Ultragenyx RARE | -$0.55 B | 206.27% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $64.31 M | -136.31% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$0.16 B | -15.16% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -$23.25 M | -86.88% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.18 B | -206.46% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -$20.53 M | -88.41% | 🇺🇸 USA |